Revance Therapeutics Inc (RVNC)
3.15
-0.01
(-0.32%)
USD |
NASDAQ |
May 20, 16:00
3.15
0.00 (0.00%)
After-Hours: 18:24
Revance Therapeutics Market Cap: 329.01M for May 20, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 315.43M |
| May 16, 2024 | 330.06M |
| May 15, 2024 | 345.72M |
| May 14, 2024 | 363.48M |
| May 13, 2024 | 346.77M |
| May 10, 2024 | 346.77M |
| May 09, 2024 | 448.08M |
| May 08, 2024 | 446.00M |
| May 07, 2024 | 457.48M |
| May 06, 2024 | 428.24M |
| May 03, 2024 | 412.57M |
| May 02, 2024 | 393.77M |
| May 01, 2024 | 396.38M |
| April 30, 2024 | 377.06M |
| April 29, 2024 | 385.27M |
| April 26, 2024 | 354.99M |
| April 25, 2024 | 343.51M |
| April 24, 2024 | 372.74M |
| April 23, 2024 | 382.14M |
| April 22, 2024 | 380.05M |
| April 19, 2024 | 394.67M |
| April 18, 2024 | 395.71M |
| April 17, 2024 | 392.58M |
| April 16, 2024 | 397.80M |
| April 15, 2024 | 414.51M |
| Date | Value |
|---|---|
| April 12, 2024 | 431.21M |
| April 11, 2024 | 463.58M |
| April 10, 2024 | 460.45M |
| April 09, 2024 | 489.68M |
| April 08, 2024 | 464.62M |
| April 05, 2024 | 460.45M |
| April 04, 2024 | 460.45M |
| April 03, 2024 | 475.06M |
| April 02, 2024 | 470.89M |
| April 01, 2024 | 493.86M |
| March 28, 2024 | 512.74M |
| March 27, 2024 | 514.83M |
| March 26, 2024 | 489.81M |
| March 25, 2024 | 484.60M |
| March 22, 2024 | 507.53M |
| March 21, 2024 | 540.88M |
| March 20, 2024 | 528.37M |
| March 19, 2024 | 513.78M |
| March 18, 2024 | 514.83M |
| March 15, 2024 | 552.86M |
| March 14, 2024 | 565.89M |
| March 13, 2024 | 627.38M |
| March 12, 2024 | 655.00M |
| March 11, 2024 | 652.39M |
| March 08, 2024 | 626.34M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
315.43M
Minimum
May 17 2024
3.161B
Maximum
May 09 2023
1.419B
Average
1.397B
Median
Market Cap Benchmarks
| AbbVie Inc | 290.61B |
| Eli Lilly and Co | 744.65B |
| Aquestive Therapeutics Inc | 289.96M |
| Humacyte Inc | 839.55M |
| AN2 Therapeutics Inc | 66.22M |
Market Cap Related Metrics
| PS Ratio | 1.162 |
| Price | 3.15 |
| Earnings Yield | -115.6% |